tiprankstipranks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Holding ELTP?
Track your performance easily

Elite Pharmaceuticals (ELTP) Financial Statements

255 Followers

Elite Pharmaceuticals Financial Overview

Elite Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.005; its P/E ratio is -104.58; Elite Pharmaceuticals is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 18.88M$ 18.80M$ 17.95M$ 15.54M$ 14.16M
Gross Profit$ 8.20M$ 8.47M$ 8.12M$ 7.04M$ 6.45M
EBIT$ -9.49M$ 882.63K$ 2.22M$ 27.37K$ -2.60M
EBITDA$ -8.93M$ 1.44M$ 2.69M$ 370.97K$ -2.27M
Net Income Common Stockholders$ -11.04M$ 615.77K$ -47.60M$ 706.40K$ 14.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.55M$ 8.41M$ 7.11M$ 5.82M$ 8.65M
Total Assets$ 88.20M$ 87.85M$ 83.65M$ 74.70M$ 70.72M
Total Debt$ 11.40M$ 11.66M$ 11.74M$ 7.89M$ 7.65M
Net Debt$ 1.84M$ 3.26M$ 4.63M$ 2.07M$ -1.00M
Total Liabilities$ 40.93M$ 29.60M$ 26.07M$ 28.28M$ 25.62M
Stockholders Equity$ 47.27M$ 58.25M$ 57.58M$ 46.41M$ 45.09M
Cash Flow-
Free Cash Flow$ 1.47M$ 1.48M$ 1.66M$ -2.80M$ -235.94K
Operating Cash Flow$ 1.46M$ 3.14M$ 2.06M$ -2.40M$ -235.94K
Investing Cash Flow$ 17.55K$ -1.66M$ -403.65K$ -406.01K-
Financing Cash Flow$ -320.69K$ -174.91K$ -361.45K$ -30.65K$ -179.50K
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

Elite Pharmaceuticals Debt to Assets

Elite Pharmaceuticals Cash Flow

Elite Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis